Consolidated income statement
January 1 – June 30
|
millions of CHF |
|
|
2025 |
|
2024 |
|
|
Sales |
|
|
1’743.9 |
|
1’699.3 |
|
|
Cost of goods sold |
|
|
|
–1’158.5 |
|
–1’126.2 |
|
Gross profit |
|
|
|
585.4 |
|
573.1 |
|
Selling and distribution expenses |
|
|
|
–163.0 |
|
–170.4 |
|
General and administrative expenses |
|
|
|
–185.1 |
|
–186.0 |
|
Research and development expenses |
|
|
|
–36.7 |
|
–36.9 |
|
Net impairment release / (loss) on contract assets and trade accounts receivable |
|
|
|
–4.2 |
|
–0.9 |
|
Other operating income / (expenses), net |
|
|
–3.7 |
|
–8.7 |
|
|
Operating income (EBIT) |
|
|
|
192.7 |
|
170.1 |
|
Interest and securities income |
|
|
7.0 |
|
9.7 |
|
|
Interest expenses |
|
|
–14.2 |
|
–14.1 |
|
|
Other financial income / (expenses), net |
|
|
–7.3 |
|
–7.3 |
|
|
Share of profit / (loss) of associates and joint ventures |
|
|
|
–9.1 |
|
–2.1 |
|
Income before income tax expenses |
|
|
|
169.1 |
|
156.3 |
|
Income tax expenses |
|
|
–40.9 |
|
–38.9 |
|
|
Net income |
|
|
|
128.2 |
|
117.4 |
|
– thereof attributable to shareholders of Sulzer Ltd |
|
|
|
127.5 |
|
116.6 |
|
– thereof attributable to non-controlling interests |
|
|
|
0.8 |
|
0.8 |
|
|
|
|
|
|
|
|
|
Earnings per share (in CHF) |
|
|
|
|
|
|
|
Basic earnings per share |
|
|
|
3.77 |
|
3.44 |
|
Diluted earnings per share |
|
|
|
3.74 |
|
3.40 |